Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - olsalazine sodium - capsule, hard - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - olsalazine sodium - tablet - 500 milligram(s) - aminosalicylic acid and similar agents; olsalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - naproxen - gastro-resistant tablet - 250 milligram(s) - propionic acid derivatives; naproxen

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - naproxen - gastro-resistant tablet - 500 milligram(s) - propionic acid derivatives; naproxen

European Union - English - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - hypercalcemia; breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases - bondronat is indicated for:prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases;treatment of tumour-induced hypercalcaemia with or without metastases.

European Union - English - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5.1). a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

European Union - English - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - solriamfetol hydrochloride - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by primary osa therapy, such as continuous positive airway pressure (cpap). 

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - lisinopril - tablet - 10 milligram(s) - ace inhibitors, plain; lisinopril

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - lisinopril - tablet - 20 milligram(s) - ace inhibitors, plain; lisinopril

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - lisinopril - tablet - 5 milligram(s) - ace inhibitors, plain; lisinopril